Here are three highlights:
1. The Senza SCS system, which delivers Nevro’s proprietary HF10 therapy, is a recently FDA-approved spinal cord stimulator for the treatment of chronic back and leg pain.
2. Traditional spinal cord stimulator therapy typically delivers electrical pulses that attempt to “mask” a patient’s sensation of pain by covering the area with paresthesias.
3. HF10 therapy relieves pain without paresthesias by using a higher frequency of electrical pulses, along with additional proprietary factors.
More articles on practice management:
10 states with most & least punitive medical boards
1st US military medical school adopts pain management curriculum: 3 things to know
5 best & 5 worst ranked states for medical quality — Which excel & which flounder?
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
